Hormone replacement therapy and other potential treatments for dementias

Endocrinology and Metabolism Clinics of North America

Volumn 26, Issue 2, 1997, Pages 329-345

  McBee, W L ^a   Dailey, M E ^a   Dugan, E ^a   Shumaker, S A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ARTICLE; DEMENTIA; ESTROGEN DEFICIENCY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MULTIINFARCT DEMENTIA; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030948737     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70250-4     Document Type: Article

References (85)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders ed 4 1994 American Psychiatric Association Washington, DC
2. K. Andersen L.J. Launer A. Ott Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? Neurology 45 1995 1441 1445
3. J.C. Anthony A. Aboraya Epidemiology of selected disorders J.E. Birren B. Sloane G.D. Cohen Handbook of Mental Health and Aging 1992 Academic Press San Diego, CA
4. M.K. Aronson W.L. Ooi H. Morgenstern Women, myocardial infarction, and dementia in the very old Neurology 40 1990 1102 1106
5. D.L. Bachman P.A. Wolf R. Linn Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study Neurology 42 1992 115 119
6. E. Barrett-Connor D. Kritz-Silverstein Estrogen replacement therapy and cognitive function in older women JAMA 269 1993 2637 2641
7. C.M. Beard E. Kokman L.T. Kurland Rheumatoid arthritis and susceptibility to Alzheimer's disease Lancet 335 1991 1426
8. C. Behl M. Widmann T. Trapp 17-beta-estradiol protects neurons from oxidative stress-induced cell death in vitro Biochem Biophys Res Commun 216 1995 473 482
9. W.G. Berlinger Low body mass index in demented outpatients J Am Geriatr Soc 39 1991 973 978
10. S.J. Birge Hip fracture [review] Clin Geriatr Med 10 1994 589 609
11. S.J. Birge Alzheimer's disease: A women's health issue Alzheimer's Disease Research: Possible Causes, Potential Treatment 1996 Poster Book, American Academy of Family Physicians New Orleans
12. J.C. Breitner B.A. Gau K.A. Welch Inverse association of anti-inflammatory treatments and Alzheimer's disease Neurology 44 1994 227 232
13. 2 blocking drugs Neurobiol Aging 16 1995 523 520
14. G.A. Broe A.S. Henderson H. Creasey A case-control study of Alzheimer's disease in Australia Neurology 40 1990 1698 1707
15. Canadian Study of Health and Aging Risk factors for Alzheimer's disease in Canada Neurology 44 1994 2073 2080
16. J.L. Cummings D.F. Benson Dementia: A Clinical Approach ed 2 1992 Butterworths Boston, MA
17. J.L. Cummings F. Benson M.A. Hill Aphasia in dementia of Alzheimer's type Neurology 35 1985 394 397
18. K.L. Davis L.J. Thal E.R. Gamzu A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease N Engl J Med 327 1992 1253 1259
19. D.A. Evans H. Funkenstein M.S. Albert Prevalence of Alzheimer's disease in a community population of older persons JAMA 262 1989 2551 2556
20. H. Fillit Estrogens in the pathogenesis and treatment of Alzheimer's disease in postmenopausal women Ann NY Acad Sci 743 1994 233 239
21. H. Fillit H. Weinreb I. Cholst Observations in a preliminary open trial of estradiol therapy for senile dementia—Alzheimer's type Psychoneuroendocrinology 11 1986 337 345
22. F.F. Finucane J.H. Madans T.L. Bush Decreased risk of stroke among postmenopausal hormone users Arch Intern Med 153 1993 73 79
23. T.M. Florence The role of free radicals in disease [review] Aust NZ J Ophthalmol 23 1995 3 7
24. M.F. Folstein S.E. Folstein P.R. McHugh Mini-mental state: A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
25. L. Frolich P. Riederer Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment [review] Arzneimittelforschung 45 1995 443 446
26. J.L. Funk K.F. Mortel J.S. Meyer Effects of estrogen replacement therapy on cerebral perfusion and cognition among postmenopausal women Dementia 2 1991 268 272
27. R.B. Gibbs D. Wu L.B. Hersh Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats Exp Neurol 129 1994 70 80
28. Y. Goodman A.J. Bruce B. Cheng Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons J Neurochem 66 1996 1836 1844
29. A.B. Graves E. White T.D. Koepsell A case-control study of Alzheimer's disease Ann Neurol 28 1990 766 774
30. B. Gurland D. Wilder P. Cross Relative rates of dementia by multiple case definitions, over two prevalence periods, in three sociocultural groups Am J Geriatr Psychiatry 3 1995 6 20
31. E.D. Hall K.E. Pazara K.L. Linseman Sex differences in post-ischemic neuronal necrosis in gerbils J Cereb Blood Flow Metab 11 1991 292 298
32. E. Hampson D. Kimura Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills Behav Neurosci 102 1988 456 459
33. K. Hasegawa The clinical assessment of dementia in the aged: A dementia screening scale for psychogeriatric patients M. Bergener Aging in the Eighties and Beyond: Highlights of the Twelfth International Congress of Gerontology 1983 Springer New York 207 218
34. V.W. Henderson A. Paganini-Hill C.K. Emanuel Estrogen replacement therapy in older women: Comparisons between Alzheimer's disease cases and nondemented control subjects Arch Neurol 51 1994 896 900
35. H. Honjo Y. Ogino K. Tanaka An effect of conjugated estrogen to cognitive impairment in women with senile dementia–Alzheimer's type: A placebo-controlled double-blind study J Jpn Menopause Soc 1 1993 167 171
36. H. Honjo K. Tanaka T. Kashiwagi Senile dementia–Alzheimer's type and estrogen Horm Metab Res 27 1995 204 207
37. A.B. Jaffe C.D. Toran-Allerand P. Greengard Estrogen regulates metabolism of Alzheimer amyloid β precursor protein J Biol Chem 269 1994 13065 13068
38. A.F. Jorm A.E. Korten A.S. Henderson The prevalence of dementia: A quantitative integration of the literature Acta Psychiatr Scand 76 1987 465 479
39. E. Josefsson A. Tarkowski H. Carlsten Anti-inflammatory properties of estrogen: In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophils Cell Immunol 142 1992 67 78
40. R.L. Kane J.G. Ouslander I.B. Abrass Essentials of Clinical Geriatrics 1994 McGraw-Hill New York
41. C.S. Kase Epidemiology of multi-infarct dementia Alzheimer Dis Assoc Disord 5 1991 71 76
42. R. Katzman Education and the prevalence of dementia and Alzheimer's disease Neurology 43 1993 13 20
43. D.I. Kaufer J.L. Cummings D. Christine Effect of tacrine on behavioral symptoms in Alzheimer's disease: An open-label study J Geriatr Psychiatry Neurol 9 1996 1 6
44. Z.S. Khachaturian Diagnosis of Alzheimer's disease Arch Neurol 42 1985 1097 1105
45. D. Kimura E. Hampson Cognitive pattern in men and women is influenced by fluctuations in sex hormones Curr Directions Psychol Sci 3 1994 57 61
46. M.J. Knapp D.S. Knopman P.R. Solomon A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease JAMA 271 1994 985 991
47. G. Li Y.C. Shen C.H. Chen A case-control study of Alzheimer's disease in China Neurology 42 1992 1481 1482
48. J. Marx Searching for drugs that combat Alzheimer's Science 273 1996 50 53
49. A. Matsumoto Y. Arai M. Osanai Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats Neurosci Res 2 1985 412 418
50. R. Mayeux Alzheimer's disease W.R. Hazzard R. Andres E.L. Bierman J.P. Blass Principles of Geriatric Medicine and Gerontology ed 2 1990 McGraw-Hill New York
51. P.L. McGeer N. Harada H. Kimura Prevalence of dementia amongst elderly Japanese with leprosy: Apparent effect of chronic drug therapy Dementia 3 1992 146 149
52. P.L. McGeer E.G. McGeer J. Rogers Anti-inflammatory drugs and Alzheimer's disease Lancet 335 1990 1037
53. P.L. McGeer J. Rogers E.G. McGeer Neuroimmune mechanisms in Alzheimer disease pathogenesis Alzheimer Dis Assoc Disord 8 1994 149 165
54. P.L. McGeer M. Schulzer E.G. McGeer Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies Neurology 47 1996 425 432
55. B.L. Miller L. Chang G. Oropilla Alzheimer's disease and frontal lobe dementias C.E. Coffey J.L. Cummings Textbook of Geriatric Neuropsychiatry 1994 American Psychiatric Press Washington, DC
56. J.C. Morris A. Heyman R.C. Mohs The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease Neurology 39 1989 1159 1165
57. D.D. Murphy M. Segal Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones J Neurosci 16 1996 4059 4068
58. R. Myllkangas-Luosujarvi H. Isomaki Alzheimer's disease and rheumatoid arthritis Br J Rheumatol 33 1994 501 502
59. Office of Technology Assessment Task Force Confronting Alzheimer's Disease and Other Dementias 1988 JB Lippincott Philadelphia, PA
60. T. Ohkura K. Isse K. Akazawa Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type Endocr J 41 1994 361 371
61. T. Ohkura K. Isse K. Akazawa Low-dose estrogen replacement therapy for Alzheimer disease in women Menopause J North Am Menopause Soc 1 1994 125 130
62. O.J. Oken P.I. McGeer Down's syndrome: Prophylaxis and therapy for the frequently comorbid Alzheimer's disease Med Hypotheses 44 1995 233 234
63. A. Paganini-Hill V.W. Henderson Estrogen deficiency and risk of Alzheimer's disease in women Am J Epidemiol 140 1994 256 261
64. S.M. Phillips B.B. Sherwin Effects of estrogen on memory function in surgically menopausal women Psychoneuroendocrinology 17 1992 485 495
65. S. Read Vascular dementias J. Sadavoy L.W. Lazarus L.F. Jarvik Comprehensive Review of Geriatric Psychiatry—II ed 2 1996 American Psychiatric Press Washington, DC
66. J.B. Rich D.X. Rasmusson M.F. Folstein Nonsteroidal anti-inflammatory drugs in Alzheimer's disease Neurology 45 1995 51 55
67. D. Robinson L. Friedman R. Marcus Estrogen replacement therapy and memory in older women J Am Geriatr Soc 42 1994 919 922
68. J. Rogers Inflammation and Alzheimer's disease Alzheimer's Disease Research: Possible Causes, Potential Treatment 1996 Poster Book, American Academy of Family Physicians New Orleans
69. J. Rogers L.C. Kirby S.R. Hempelman Clinical trial of indomethacin in Alzheimer's disease Neurology 43 1993 1609 1611
70. L.S. Schneider M.R. Farlow V.W. Henderson Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease Neurology 46 1996 1580 1584
71. Schneider LS, Farlow MR, Pogoda JM, et al: Interaction of estrogen replacement therapy and apolipoprotein E genotype status on response to cholinesterase inhibitor therapy in Alzheimer's disease. Presented at the 5th International Conference on Alzheimer's disease, Osaka, Japan, July 1996
72. B.B. Sherwin Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women Psychoneuroendocrinology 13 1988 345 357
73. M. Singh E.M. Meyer W.J. Millard Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats Brain Res 644 1994 305 312
74. M. Singh E.M. Meyer J.W. Simpkins The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats Endocrinology 136 1995 2320 2324
75. D.A. Snowden S.J. Kemper J.A. Mortimer Linguistic ability in early life correlates with cognitive function and Alzheimer's disease in late life JAMA 275 1996 528 532
76. J. Stephenson More evidence links NSAID, estrogen use with reduced Alzheimer risk JAMA 275 1996 1389 1390
77. Y. Stern B. Gurland T.K. Tatemichi Influence of education and occupation on the incidence of Alzheimer's disease JAMA 271 1994 1004 1010
78. M.-X. Tang D. Jacobs Y. Stern Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease Lancet 348 1996 429 432
79. E.L. Teng H.C. Chui The modified mini-mental state (3MS) examination J Clin Psychiatry 48 1987 314 318
80. R.D. Terry R. Katzman Senile dementia of the Alzheimer type Ann Neurol 14 1983 497 506
81. C.D. Toran-Allerand Mechanisms of estrogen action during neural development: Mediation by interactions with the neurotrophins and their receptors? J Steroid Biochem Mol Biol 56 1996 169 178
82. C.D. Toran-Allerand R.C. Miranda W.D.L. Bentham Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain Proc Natl Acad Sci USA 89 1992 4668 4672
83. C.S. Woolley B.S. McEwen Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat J Neurosci 12 1992 2549 2554
84. C.S. Woolley B.S. McEwen Estradiol regulates hippocampal dendritic spine density via an N -Methyl-D-Aspartate receptor-dependent mechanism J Neurosci 14 1994 7680 7687
85. J.A. Yesavage Geriatric depression scale Psychopharm Bull 24 1988 709 711